
| 2016 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2015 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2023 | 0 | 437.000 | 13.800 | 1 | ||
| 2016 | 0 | 346.500 | 13.500 | 1 | ||
| 2015 | 0 | 567.000 | 4.500 | 1 | ||
Total number of partners: 31
Partner loyalty:
Frequent Partner: (> 2 projects): 6
Rare Partner: 25
Frequent / Rare Partner Ratio: 0.24
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2023-01-01 | Heparanase inhibition as a multifunctional targeting approach in cancer | HEPINIB | participant | 437.000 | 12 |
| 2016-01-01 | Molecular Mechanisms of Endometriosis | MOMENDO | participant | 346.500 | 9 |
| 2015-07-01 | Matrix glycans as multifunctional pathogenesis factors and therapeutic targets in cancer | GLYCANC | participant | 567.000 | 13 |